RemedyBio’s CSO Dr. Paul Leonard is leading an independent validation study of commercially available COVID-19 serological tests, with the aim of recommending the best in class tests for nationwide seroprevalence studies in Ireland. This project is funded by DCU’s COVID-19 Research and Innovation Hub.
Recommended For You
RemedyBio today announces a new collaborative research project with the Thoracic Oncology Research Group (TORG)
Remedy BiologicsNovember 24, 2021